版本:
中国

BRIEF-Aquinox Pharmaceuticals Qtrly loss per share $0.36

May 9 Aquinox Pharmaceuticals Inc:

* Aquinox Pharmaceuticals announces first quarter 2017 financial results

* Qtrly loss per share $0.36

* Aquinox Pharmaceuticals Inc - top line data from leadership 301 trial is anticipated in 2018

* Aquinox Pharmaceuticals Inc - continue to expect that our cash-on-hand will carry us beyond top-line data from 301 trial and into 2019 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐